Find Academic Supervisors

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +12 more

Associate Professor Arnold Lining Ju is a biomedical engineer at the University of Sydney's School of Biomedical Engineering, affiliated with multiple institutes including the Heart Research Institute and Sydney Nano Institute. He holds academic positions in both the Faculty of Engineering and Faculty of Medicine & Health. Education: BSc from Peking University, PhD from Georgia Tech and Emory University (USA). Honors include Snow Fellowship, Heart Foundation Future Leader Fellowship, and multiple awards for cardiovascular research innovation. Research focuses on mechanobiology and biomechanics of thrombosis, developing microfluidic devices and organ-on-chip systems. Key projects include AI-driven single-cell nanotools, 3D biofabrication, and anti-thrombotic peptide design. Leads interdisciplinary teams and collaborates internationally with institutions like Harvard and University of Texas. Teaching roles include coordinating advanced cellular biomechanics courses and supervising PhD/Masters students in biomedical engineering and physiology. Over 50 peer-reviewed publications, with contributions to Nature Materials, Nature Communications, and other top journals.

• Mechanobiology
• Biomechanics
• Organ-on-chip
• +5 more

Dr. Thanh Nho Do is a Scientia Senior Lecturer at the Graduate School of Biomedical Engineering (GSBmE), UNSW Sydney, and Director of the UNSW Medical Robotics Lab. He holds a PhD in Mechanical Engineering (Surgical Robotics) from Nanyang Technological University (NTU), Singapore, and a B.Eng. in Manufacturing Engineering from Ho Chi Minh City University of Technology, Vietnam. His research focuses on soft robotics, wearable technologies, and biomedical devices, including flexible surgical systems, soft actuators, and haptic interfaces. Education PhD in Mechanical Engineering (Surgical Robotics), NTU Singapore, 2015 B.Eng. in Manufacturing Engineering, Ho Chi Minh City University of Technology, Vietnam Research Interests Soft robotics for medical applications (e.g., NOTES systems, wearable haptics) Functional materials for biomedical devices Cardiovascular engineering and assistive devices Advanced control algorithms for medical robotics Key Contributions His work spans bioprinting, motor-free robotic systems, and soft wearable technologies. Recent studies include self-deploying cardiac compression devices and bioinspired artificial muscles. Awards 2025: CINSW Career Development Fellow 2024: NSW Young Tall Poppy Science Award 2023: Best Poster Awards at EMBC and ICRA Grants & Funding Includes NHMRC Ideas Grant (Lead CI), Cancer Institute NSW Fellowship, and UNSW Scientia Grant. Active projects address cardiovascular interventions and wearable robotics. Labs & Teams Leads the UNSW Medical Robotics Lab, collaborating on devices like soft robotic catheters and textile-driven exosuits.

• Biomedical Engineering
• Surgical Robotics
• Soft Robotics
• +5 more

Dr. Lucy Gloag is a Lecturer at the Research School of Chemistry at the Australian National University (ANU), where she joined in 2024 after previously serving as a Lecturer at the University of Technology Sydney in 2023. Her research focuses on the development of advanced nanomaterials for energy applications, particularly in electrocatalysis and energy storage. Education: BSc/BCA and BSc(Hons) from Victoria University of Wellington, New Zealand PhD from the University of New South Wales (2018) on synthesis and characterization of Ru-based nanocatalysts Dr. Gloag is a nanomaterials chemist and electron microscopist specializing in the synthesis and characterization of nanomaterials for electrocatalytic applications. Her research addresses the fundamental question of how nanostructure can be used to enhance the performance of electrocatalysts . She employs solution-phase synthesis techniques to create nanoparticles with precise control over crystal structure, dimensions, and surface faceting, then correlates these structural features with electrocatalytic properties using transmission electron microscopy and electrochemistry. Her work spans energy conversion technologies, biomedical applications of nanoparticles, and advanced materials characterization. Analysis of her recent publications reveals a strong focus on single-atom catalysts, hierarchical nanostructures, and the relationship between nanomaterial structure and function. Her research spans both fundamental materials science and practical applications in energy conversion, with significant work on oxygen evolution reaction, hydrogen evolution reaction, and methanol oxidation electrocatalysts. She has also made notable contributions to biomedical applications of nanoparticles, particularly in magnetic particle imaging and Alzheimer's disease diagnostics. Scientific Awards: ARC Discovery Project Grant (2023) ARC Linkage Project Grant (2023) UNSW Science COVID19 Strategic Support Grant (October 2021) Dementia Australia Research Foundation – Yulgilbar Innovation Grant (2019-2022) Australian Postgraduate Research Scholarship (2015) AMN-7 Image Competition Finalist (2015) Dr. Gloag currently leads the ANU Futures Scheme 2.0 project (2024-2028) and has secured multiple competitive research grants, demonstrating strong research leadership. Her work involves extensive collaboration with researchers at UNSW and other institutions, particularly with Professors Richard Tilley and Justin Gooding. She has published 28 research outputs since 2015, with significant citation impact (h-index of 17). Her laboratory at ANU (Building 137, room 2.49) focuses on developing single atom and nanomaterials for energy storage and conversion technologies, continuing her trajectory as an emerging leader in advanced materials synthesis and electron microscopy characterization.

• Nanomaterials Chemistry
• Electron Microscopy
• Electrocatalysis
• +3 more

Professor Ravi Shukla is a faculty member at RMIT University's School of Science, holding the title of Professor and Deputy Head of Department (Research). He specializes in Nanobiotechnology, with research spanning biomaterials, drug delivery systems, and medical diagnostics. His work integrates biosciences, materials science, and food technology to advance understanding of nanomaterial-biomolecular interactions. Academic History: Professor Shukla has held roles at RMIT since 2011, progressing from Research Fellow to his current professorship. He also serves as an Adjunct Professor at the University of Missouri and Theme Leader for Nanobiotechnology at RMIT’s Center for Advanced Materials and Industrial Chemistry. His teaching focuses on fostering student belonging and innovation in biotechnology education, including coordinating RMIT’s undergraduate Biotechnology program. Research Interests: His lab explores hybrid biomaterial synthesis, nano-enabled proteomics, and non-viral gene therapy using MOFs. Recent work emphasizes applications in diabetes biosensing, CRISPR/Cas9 delivery, and antimicrobial resistance mitigation through nanostrategies. Over 130+ publications and substantial research funding highlight his interdisciplinary impact. Professional Engagement: Editor roles in Frontiers in Bioengineering and Biotechnology , Co-Editor-in-Chief of Current Research in Nutrition and Food Science , and advisor to the Australasian Association of Ayurveda underscore his leadership. He actively mentors students in projects like nano-antimicrobial wound healing and aptamer-based hepatitis A detection. Key Achievements: Pioneered nucleic acid-encapsulated MOFs for cancer therapy and developed paper-based biosensors for rapid diagnostics. His work aligns with UN Sustainable Development Goals 2 (Zero Hunger) and 3 (Good Health).

• Nanobiotechnology
• Bioscience
• Medical Biotechnology
• +6 more

Niels Quack is an Associate Professor in Micro- and Nanosystems at The University of Sydney's School of Aerospace, Mechanical and Mechatronic Engineering. He joined the university in 2022 after serving as an SNSF Assistant Professor at EPFL (Switzerland). His roles include Academic Director of the Research and Prototype Foundry and membership in the University of Sydney Nano Institute. He holds a Dr.Sc. from ETH Zurich and an M.Sc. from EPFL. His research focuses on micro- and nanosystems engineering, integrating mechanics and photonics at the microscale. Key applications include fiber-optical communication, quantum sensing, and integrated photonics using diamond and silicon materials. Quack has pioneered silicon photonic MEMS and diamond micro-optics, with over 100 publications in journals like ACS Photonics , Optics Letters , and Nanoscale . He leads international collaborations with institutions like Ghent University (Belgium) and EPFL (Switzerland), and serves on editorial boards for IEEE Journal of Microelectromechanical Systems and SPIE Journal of Optical Microsystems . His awards include the Optica Senior Member distinction (2023) and Sydney Research Accelerator Prize (2023). Quack supervises PhD and Master's students in advanced micro- and nanosystems design, offering projects in programmable photonics and diamond-based biosensors. He actively recruits postdoctoral researchers and advises on funded projects like 'Nurturing Commercialization Opportunities for Multipoint Fiber-Optical Pressure Sensors.' His lab develops cutting-edge technologies such as vacuum-sealed silicon photonic MEMS and diamond nanopillar arrays, advancing applications in quantum sensing and optical communication systems.

• Micro- and Nanosystems Engineering
• Photonics
• MEMS (Microelectromechanical Systems)
• +5 more

Adjunct Professor Robert Speight holds a position at Queensland University of Technology (QUT) within the Faculty of Science, School of Biology & Environmental Science. His primary role is Director of CSIRO's Advanced Engineering Biology Future Science Platform. He focuses on microbial biotechnology, enzyme engineering, and industrial biotechnology applications. His research spans protein engineering, microbial production systems, and biocatalyst development for industrial processes. Education: BSc (Chemistry) from Imperial College London (1996) PhD in Biochemistry from the University of Cambridge (2000) Research Interests: Enzyme optimization for industrial applications Microbial protein production systems Biocatalytic processes for chemical manufacturing Biorefinery development and techno-economic assessments Synthetic biology for future foods and sustainable bioproduction Grants & Projects: Lead investigator for the $6.5M Queensland Sustainable Aviation Fuel Initiative ARC Centre of Excellence in Synthetic Biology (2020–present) Biorefineries for Profit Phase 2 (RnD4Profit 2019) Collaborations: Works with industry partners and academic groups, including the ARC Centre of Excellence in Synthetic Biology and the Centre for Agriculture and Bioeconomy at QUT. Affiliations: President of Synthetic Biology Australasia CSIRO Director of Advanced Engineering Biology Future Science Platform Labs/Teams: Maintains collaborations in enzyme engineering and microbial systems through QUT’s adjunct role and CSIRO leadership.

• Industrial Biotechnology
• Synthetic Biology
• Enzyme Engineering
• +4 more

Professor Craig Priest is a faculty member at the University of South Australia within UniSA STEM , focusing on microfluidics , optofluidics , and interfacial science applications. He serves as a Research Degree Supervisor and has contributed to advancements in sensor technology, biomedical engineering, and materials science. Key Research Themes : Development of micropillar array-integrated sensors for rapid vapor detection 3D-printed microstructures to mitigate matrix effects in electrochemical sensing Wettability engineering for passive fluid control in lab-on-a-chip devices PDMS-PS bonding protocols enabling robust cell culture platforms like Heart-Dyno Collaborations & Grants : Collaborated with Queensland University of Technology and QIMR Berghofer on biomedical devices Involved in ARC grants: ARC IH150100028 and ARC DP1094337 Industry partnerships with BHP Billiton and ULVAC Inc. Academic Contributions : Published in IEEE Sensors , APL Materials , and ACS Applied Materials & Interfaces Active in microfluidic device design for biomedical and environmental applications Developed evaporation-driven fluid transport systems for portable biosensing platforms

• Microfluidics
• Optofluidics
• Sensor Technology
• +4 more

Carlos Salomon Gallo is a Professor and NHMRC Investigator Fellow (EL2) at The University of Queensland's Centre for Clinical Research, affiliated with the School of Biomedical Sciences. He directs the Centre for Extracellular Vesicle Nanomedicine and leads the Exosome Biology Laboratory. A globally recognized key opinion leader in extracellular vesicles (ranked 3rd worldwide by Expertscape), his research focuses on EV biology for diagnostic and therapeutic applications in ovarian cancer, gestational diabetes, preeclampsia, and other obstetrical syndromes. His research integrates proteomics (SWATH-MS), miRNA analysis, and advanced isolation techniques to develop liquid biopsies. Core interests include: EV biomarker discovery and validation for early disease detection. Mechanisms of EV-mediated signaling in metabolic and oncological pathologies. Engineering EVs for targeted drug delivery and CRISPR-Cas therapeutics. Clinical translation of EV-based diagnostics (IVDs) and therapeutics. Analysis of his recent articles reveals a dominant focus on EV profiling in pregnancy complications (gestational diabetes, preeclampsia) and oncology (ovarian cancer), utilizing multi-omics approaches. Key trends include developing high-sensitivity EV biosensors, understanding hypoxia-induced EV signaling, and exploring 3D models for EV research. He has received significant recognition, including: NHMRC Emerging Leadership Fellow NHMRC Investigator Fellow (EL2) He leads the Exosome Biology Laboratory and the UQ Centre for Extracellular Vesicle Nanomedicine, fostering cross-disciplinary collaboration. His work involves extensive national and international partnerships, evidenced by leadership roles in the Centre for Clinical Diagnostics and over 20 invited international talks in 5 years. He actively mentors HDR students and contributes to global EV research standards (MISEV2023).

• Extracellular Vesicles
• Biomarker Discovery
• Exosome Biology
• +7 more

Dr. Shelley Wickham is an Associate Professor and ARC DECRA Fellow at the University of Sydney, holding joint appointments in the Schools of Chemistry and Physics. She serves as a Westpac Research Fellow and leads the DNA Nanotechnology Group at the Sydney Nano Institute. Dr. Wickham is also co-Champion of the Sydney Nano Institute Grand Challenge project in Molecular Nanorobotics for Health, co-lead of the School of Physics Grand Challenge on Nanoscale brain navigation for targeted drug delivery, and faculty mentor of the University of Sydney BIOMOD team. Bachelor of Science and Master of Science in Physics from University of Sydney PhD in Condensed Matter Physics from University of Oxford Postdoctoral Fellow at Harvard Medical School, Dana-Farber Cancer Institute, and Wyss Institute Dr. Wickham's research focuses on self-assembling nanotechnology and molecular robotics, particularly in the design and assembly of programmable nanostructures out of DNA. Her work spans applications in cell biology, materials science, and nanomedicine. Current research projects include design and synthesis of self-assembling DNA nanostructures, proto-cells made of DNA gels that move under flow, new plasma fabrication methods for biomolecule micropatterning, and DNA computation circuits for navigating the brain using machine learning. Her research aligns with the Faculty of Science Research Strengths in Molecules to Materials, Preventing and Treating Disease & Disorder, and Next Generation Materials. Analysis of Dr. Wickham's recent publications reveals a consistent focus on DNA nanotechnology with increasing sophistication in structural complexity and biological applications. Her work has evolved from fundamental DNA origami structures to increasingly complex multi-component systems with practical applications in nanomedicine and biomimetic engineering. Recent publications show strong interdisciplinary collaboration across chemistry, physics, biology, and engineering disciplines, with emphasis on real-world applications including drug delivery systems and biomolecular sensors. ARC DECRA Fellow Westpac Research Fellow BIOMOD World Champions (2019) Dr. Wickham actively mentors PhD students and postdoctoral researchers in her DNA nanotechnology group. She has secured significant research funding including ARC Discovery Projects, Westpac Scholarships, and NSW Health grants. Her current grants support projects such as '3D Bio-Nanomaterial Displays with Designer Architectures and Functions' and 'RNA aptamer sensing devices for rapid detection of blood clotting.' Dr. Wickham encourages applications from diverse backgrounds and maintains active collaborations with researchers at Harvard, Oxford, and other international institutions. Dr. Wickham leads the DNA Nanotechnology Group at the University of Sydney, which is part of the Sydney Nano Institute. Her lab focuses on building tools from DNA origami - including tweezers, spanners, wrenches and springs - to better understand biological processes at the nanoscale. The group has achieved notable success with the BIOMOD team winning world championships in 2019, and continues to develop innovative approaches to molecular robotics for healthcare applications.

• DNA Nanotechnology
• Molecular Robotics
• Self-Assembling Nanostructures
• +4 more

Wei Deng is an Associate Professor and Deputy Head of School (Research) in the School of Biomedical Engineering at the University of Technology Sydney (UTS). Her research focuses on cancer nanotechnology, nanobiotechnology, and gene engineering, with significant contributions to radiation-activated chemotherapy (RAC) via liposomes and CRISPR-based therapies. She has pioneered treatments for rectal and breast cancers, including the development of patented RAC systems that reduce chemotherapy toxicity. Her work has led to the founding of biotech startup EosGene Pty Ltd for diabetic retinopathy therapies. Deng holds a PhD from Macquarie University and has attracted over $3.7M in grants from ARC, NHMRC, and Cancer Institute NSW. She leads interdisciplinary teams and contributes to global collaborations, including partnerships with UNSW and HK Winhealth Pharma Group. Her research spans drug/gene delivery systems, CRISPR biosensors, and nanoparticle engineering, emphasizing translational medicine and industrial challenges. Education: PhD in Biomedical Engineering, Macquarie University (Sydney) Leadership Roles: Deputy Head of School, Research; Co-founder of EosGene Pty Ltd Awards: DECRA Fellowship (ARC), Cancer Institute NSW Career Development Fellowship Key Projects: RAC liposomes (Patents US 12036282, Europe 3720422), CRISPR-based pathogen sensors, X-ray triggered PDT platforms Her research bridges nanotechnology and clinical applications, with 62 refereed publications (h-index 26) and 87% in top-tier journals. She actively supervises postgraduate research in CRISPR therapies, CAR T cell engineering, and targeted drug delivery.

• Cancer Nanotechnology
• Nanomedicine
• Gene Engineering
• +7 more

Jun Chen is a Senior Professor at the University of Wollongong, affiliated with the Intelligent Polymer Research Institute within the Australian Institute for Innovative Materials. He holds a PhD from the University of Wollongong (2003). His research focuses on nanomaterials, electrocatalysis, energy storage, and fuel cell technologies. Key interests include carbon nanotube architectures, sustainable energy materials, and bionic device development. He has received notable awards such as the Clarivate Highly Cited Researcher (2020, 2018) and the Royal Society of Chemistry Fellowship (2021). Research activities emphasize design of novel electrocatalysts for hydrogen storage, CO₂ reduction, and water splitting. His group explores 3D-printed biocompatible materials and wearable energy systems. He leads projects on nanomaterial synthesis and electrochemical systems, supported by ARC grants. Supervision covers topics like electrochemical stimulation systems and energy storage interfaces. Professional service includes roles in academic leadership and editorial boards. Key contributions include patents on carbon nanotube architectures and over 360 publications. His work bridges nanotechnology with sustainable energy and biomedical applications, aiming to advance eco-friendly energy conversion and regenerative medicine.

• Electrocatalysis
• Nanomaterials and Nanotechnology
• Energy Storage and Conversion
• +4 more

Assoc. Professor Enbang Li is a Senior Lecturer at the School of Physics within the Faculty of Engineering and Information Sciences at the University of Wollongong. His research focuses on photonics, medical physics, and optical sensor technologies with applications in radiation dosimetry, biomedical engineering, and wearable devices. He has supervised numerous PhD and Master’s students in areas such as fiber-optic dosimetry for radiotherapy, blood glucose sensing, and microfluidics. His work includes advancements in fiber-optic dosimeters for MRI-LINAC systems, polymer-based biosensors for glucose monitoring, and integrated photonic sensors for temperature and pressure measurements. He has secured funding from organizations like the Australian Synchrotron Research Program and the University of Wollongong for projects related to dosimetry and photonic integration. Recent publications highlight innovations in HDR brachytherapy dosimetry, flexible electro-optic modulators for ECG signals, and lab-on-a-chip systems. His research also extends to material science, including corrosion studies of Al-Mg alloys and the dynamic behavior of sunscreens under in-service conditions.

• Photonics
• Medical Physics
• Optical Sensors
• +3 more

Andrew Currie is a Professor and Associate Dean (Research & Innovation) at Murdoch University's School of Medical, Molecular and Forensic Sciences, within the College of Environmental and Life Sciences. He leads the Sepsis Diagnostics Research Group at the Centre for Molecular Medicine and Innovative Therapeutics and co-heads the Neonatal Infection and Immunity Team with Clinical Professor Tobias Strunk at the Wesfarmers Centre of Vaccine & Infectious Diseases at Telethon Kids Institute. His research focuses on immunology and infectious diseases in pediatric populations, particularly sepsis diagnostics and neonatal immunity. Education: PhD (Immunology, University of Western Australia, 2001); BSc (Biotechnology with Honors, Murdoch University, 1997). Research Interests: Sepsis diagnostics, innate immunity mechanisms in neonates, medical biotechnology for diagnostics (e.g., biosensors), and translational research in pediatric infections. Collaborates internationally with institutions in Canada, Denmark, the UK, US, and China. Aims to reduce sepsis burden in vulnerable populations through advanced molecular methods and interdisciplinary partnerships. Key Affiliations: Lead of Sepsis Diagnostics Research Group (Murdoch University), Senior Lecturer in Immunology, Honorary Associate at Kids Research Institute Australia. Past roles include leadership in the Centre for Molecular Medicine and Innovative Therapeutics. Scientific Contributions: Over 100 peer-reviewed articles focusing on sepsis biomarkers, neonatal immunity, tick-borne diseases, and clinical trials for interventions like vitamin C and probiotics in critical illness. Active in developing precision medicine approaches for neonatal sepsis. Grants & Funding: Co-leads major projects on sepsis diagnostics and neonatal infection, supported by national and international grants. Collaborates on multi-institutional initiatives. Labs/Teams: Sepsis Diagnostics Research Group (Murdoch) and Neonatal Infection and Immunity Team (Telethon Kids Institute). Works closely with the Personalised Medicine Centre and Health Futures Institute.

• Sepsis
• Innate Immunity
• Neonatal Immunology
• +5 more

Dr. Chang Lei is an ARC Discovery Early Career Researcher Award (DECRA) Fellow at the Department of Medical Sciences within the Faculty of Medicine and Health at The University of Sydney. She is also a member of The University of Sydney Nano Institute and the Charles Perkins Centre. With expertise in nanotechnology-based bioanalysis, mass spectrometry, lateral flow immunoassay, and tissue regeneration, Dr. Lei leads several innovative research projects focused on advancing healthcare through nanotechnology. Dr. Lei completed her PhD at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland (UQ). Her academic journey includes receiving the Queensland Government Advance Queensland Research Fellowship, the UQ Amplify Fellowship in 2021, and the prestigious ARC DECRA in 2024. Her research interests span across nanotechnology applications in healthcare, with particular focus on: Developing novel nanomaterials for single-cell metabolomics analysis Creating affordable and ultra-sensitive biomarker detection platforms Engineering silica bio-nanomaterials for stem cell differentiation and bone repair Advancing lateral flow immunoassay technologies using nanomaterials Applying nanotechnology to dental and craniofacial regeneration Dr. Lei's publication record demonstrates a strong focus on nanotechnology applications across multiple disciplines. Her recent work shows increasing emphasis on medical applications of nanomaterials, particularly in diagnostics, cancer therapy, and tissue regeneration. She has published in high-impact journals including Nature Science Review, Small, Biosensors and Bioelectronics, Angewandte Chemie, and Advanced Materials. Dr. Lei has received several notable awards and honors: 2024 ARC DECRA Fellow 2021 The University of Queensland Amplify Fellow 2020 GC Minimum Intervention Dentistry Research Award 2017 Advanced Queensland Research Fellow As a reviewer for scientific journals such as Science Advances, Journal of Nanobiotechnology, and Journal of Materials Chemistry B, and for ARC and NHMRC grants, Dr. Lei actively contributes to the scientific community. She also serves as an editor for Frontiers in Bioengineering and Biotechnology and Nano TransMed. Her current research projects are supported by grants including the ARC DECRA and the FMH Start-up Scheme. Dr. Lei is actively involved in several research groups and initiatives: Member of The University of Sydney Nano Institute Member of the Charles Perkins Centre Member of Australian and New Zealand Society for Mass Spectrometry Member of The Australian Materials Research Society Member of the Australian Nanotechnology Network

• Nanotechnology-based bioanalysis
• Mass spectrometry
• Lateral flow immunoassay
• +5 more